Lv11
6 积分 2024-06-04 加入
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
1小时前
已完结
Role for the p53 homologue p73 in E2F-1-induced apoptosis
1小时前
已完结
Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE®) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study
1天前
已完结
Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
1天前
已完结
Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications
2天前
已完结
Exploring NNMT: from metabolic pathways to therapeutic targets
22天前
已完结
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
27天前
已完结
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis
1个月前
已完结
Crosstalk between IGF-1R and other tumor promoting pathways
1个月前
已完结
皖公网安备34019202002308
